MicroRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma

International Journal of Molecular Medicine

Volumn 30, Issue 6, 2012, Pages 1321-1326

  Zhu, Xu Chao ^a   Dong, Qiong Zhu ^a   Zhang, Xiao Fei ^a   Deng, Biao ^a   Jia, Hu Liang ^a   Ye, Qin Hai ^a   Qin, Lun Xiu ^a   Wu, Xing Zhong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

AKT; Hepatocellular carcinoma; MiR 29a; SPARC

Indexed keywords

LENTIVIRUS VECTOR; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA 29A; OLIGONUCLEOTIDE; OSTEONECTIN; PROTEIN KINASE B;

3' UNTRANSLATED REGION; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HEK293; GENE CONSTRUCT; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

ADULT; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84869401271     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1140     Document Type: Article

References (25)

1. Burak KW and Kneteman NM: An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithm. Can J Gastroenterol 24: 643-650, 2010.
2. Li SF, Hawxby AM, Kanagala R, Wright H and Sebastian A: Liver transplantation for hepatocellular carcinoma: indications, bridge therapy and adjuvant therapy. J Okla State Med Assoc 105: 12-16, 2012.
3. Bouzin C and Feron O: Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery. Drug Resist Updat 10: 109-120, 2007. (Pubitemid 47031051)
4. Alonso SR, Tracey L, Ortiz P, et al: A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res 67: 3450-3460, 2007. (Pubitemid 46724886)
5. Shi Q, Bao S, Maxwell JA, et al: Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation. J Biol Chem 279: 52200-52209, 2004. (Pubitemid 39656594)
6. Thomas R, True LD, Bassuk JA, Lange PH and Vessella RL: Differential expression of osteonectin/SPARC during human prostate cancer progression. Clin Cancer Res 6: 1140-1149, 2000. (Pubitemid 30159378)
7. Chan SK, Griffith OL, Tai IT and Jones SJ: Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev 17: 543-552, 2008. (Pubitemid 351469203)
8. Lau CP, Poon RT, Cheung ST, Yu WC and Fan ST: SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J Pathol 210: 459-468, 2006. (Pubitemid 44830606)
9. Jia CY, Li HH, Zhu XC, et al: MiR-223 suppresses cell proliferation by targeting IGF-1R. PLoS One 6: e27008, 2011.
10. Wu LH, Li HH, Jia CY, et al: MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett 586: 1038-1043, 2012.
11. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007. (Pubitemid 47187346)
12. Budhu A, Jia HL, Forgues M, et al: Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47: 897-907, 2008. (Pubitemid 351449681)
13. Hou J, Lin L, Zhou W, et al: Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19: 232-243, 2011.
14. Xiong Y, Fang JH, Yun JP, et al: Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51: 836-845, 2010.
15. Li R, Qian N, Tao K, You N, Wang X and Dou K: MicroRNAs involved in neoplastic transformation of liver cancer stem cells. J Exp Clin Cancer Res 29: 169, 2010.
16. Wang B, Komers R, Carew R, et al: Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 23: 252-265, 2012.
17. Zhang P, Huang A, Ferruzzi J, et al: Inhibition of microRNA-29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels - brief report. Arterioscler Thromb Vasc Biol 32: 756-759, 2012.
18. Papadopoulou AS, Dooley J, Linterman MA, et al: The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-alpha receptor. Nat Immunol 13: 181-187, 2012.
19. Teichler S, Illmer T, Roemhild J, Ovcharenko D, Stiewe T and Neubauer A: MicroRNA29a regulates the expression of the nuclear oncogene Ski. Blood 118: 1899-1902, 2011.
20. Pandey AK, Verma G, Vig S, Srivastava S, Srivastava AK and Datta M: miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells. Mol Cell Endocrinol 332: 125-133, 2011.
21. Desjobert C, Renalier MH, Bergalet J, et al: MiR-29a downregulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Blood 117: 6627-6637, 2011.
22. Mott JL, Kurita S, Cazanave SC, Bronk SF, Werneburg NW and Fernandez-Zapico ME: Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem 110: 1155-1164, 2010.
23. Huang S and He X: The role of microRNAs in liver cancer progression. Br J Cancer 104: 235-240, 2011.
24. Roderburg C, Urban GW, Bettermann K, et al: Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53: 209-218, 2011.
25. Kong G, Zhang J, Zhang S, Shan C, Ye L and Zhang X: Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One 6: e19518, 2011.